In strong support of this notion, targeting USP28 in a model of lung SCC (“KPL mice”) using the CRISPR/Cas9 system reduced the total number of tumours and, specifically, abrogated the formation of the SCC subtype. This evidence concerns the gene USP28 and neoplasm.